Trial no.:
|
PACTR201808140151322 |
Date of Approval:
|
13/08/2018 |
Trial Status:
|
Registered in accordance with WHO and ICMJE standards |
|
TRIAL DESCRIPTION |
Public title
|
Oesophageal Doppler compared to Plethysmographic Variability Index to Guide Perioperative Fluid Management for Cirrhotic Patients undergoing Liver Resection |
Official scientific title |
Oesophageal Doppler compared to Plethysmographic Variability Index to Guide Perioperative Fluid Management for Cirrhotic Patients undergoing Liver Resection: A randomized controlled study |
Brief summary describing the background
and objectives of the trial
|
Fluid therapy during hepatic surgery has to be balanced so as to ensure adequate tissue perfusion and cellular oxygenation while avoiding fluid overload and hepatic congestion, which can lead to difficult dissection and potentially excessive bleeding. Fluid restriction by targeting a low CVP has been recommended for liver resections. Low CVP (below 5 mmHg) has been associated with decreased blood loss. There is also an increased risk of postoperative renal injury. On the other hand, excessive fluid administration results in difficult liver dissection and excessive bleeding as well as subsequent risk of fluid overload. Following hepatic resection, rehydration to a euvolemic state is utilized to ensure adequate perfusion to vital organs. According to the recommendations of the enhanced recovery after surgery( ERAS) working group, fluid overload prevention is important. Surgical access to posterior liver tumours may involve transient compression of the inferior vena cava, which can cause profound hypotension. Fluid transfusion will maintain blood pressure during these episodes but will also elevate CVP and promote bleeding. The best management of this situation involves cautious fluid transfusion and close communication with the surgical team. Positive end expiratory pressure not only reduces lung atelectasis but also elevates CVP and reduces liver blood flow, so should be avoided during the resection process. Transesophageal Doppler (TED) is a minimal invasive bedside monitor that can allow the continuous monitoring of several hemodynamic variables, with this technique a pulsed, competitive-frequency continuous-wave Doppler signal is emitted from a probe placed in the distal esophagus and directed at the descending thoracic aorta. • The primary aim is to investigate the Plethysmographic Variability Index compared to parameters obtained from transesophageal doppler for monitoring and management of fluid guided management during and after liver resection and |
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Digestive System |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Treatment: Devices |
Anticipated trial start date |
01/09/2018 |
Actual trial start date |
01/09/2018 |
Anticipated date of last follow up |
01/09/2019 |
Actual Last follow-up date |
01/09/2019 |
Anticipated target sample size (number of participants) |
40 |
Actual target sample size (number of participants) |
40 |
Recruitment status |
Recruiting |
Publication URL |
|
|